| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,390 |
15,527 |
$1.17M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,426 |
13,193 |
$649K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13,483 |
11,795 |
$617K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,713 |
6,816 |
$501K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15,723 |
12,453 |
$372K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,688 |
4,196 |
$341K |
| 99492 |
|
1,346 |
1,065 |
$134K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,169 |
1,648 |
$133K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,679 |
1,217 |
$118K |
| 99493 |
|
1,062 |
921 |
$95K |
| 59410 |
|
120 |
92 |
$94K |
| 0240U |
|
653 |
610 |
$89K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
580 |
547 |
$80K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
965 |
800 |
$67K |
| 99215 |
Prolong outpt/office vis |
656 |
605 |
$59K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,518 |
1,094 |
$59K |
| 99494 |
|
911 |
760 |
$54K |
| 59025 |
Fetal non-stress test |
1,540 |
1,040 |
$51K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,948 |
2,215 |
$37K |
| D1206 |
Topical application of fluoride varnish |
2,379 |
1,994 |
$33K |
| 99484 |
|
932 |
838 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,612 |
2,984 |
$28K |
| 0503F |
|
1,150 |
942 |
$28K |
| 90715 |
|
720 |
576 |
$28K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
501 |
430 |
$26K |
| 36415 |
Collection of venous blood by venipuncture |
10,244 |
8,252 |
$23K |
| 90686 |
|
4,326 |
3,806 |
$20K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
215 |
180 |
$19K |
| D0190 |
|
2,385 |
1,994 |
$19K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,452 |
1,969 |
$19K |
| 96127 |
|
4,293 |
3,430 |
$17K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
488 |
367 |
$15K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
191 |
141 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
700 |
535 |
$15K |
| 81025 |
|
2,550 |
2,011 |
$13K |
| 0011A |
|
387 |
308 |
$10K |
| 87428 |
|
180 |
155 |
$10K |
| 99177 |
|
1,792 |
1,328 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
223 |
188 |
$8K |
| 99460 |
|
146 |
138 |
$7K |
| 98960 |
|
145 |
113 |
$7K |
| 0012A |
|
272 |
206 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
445 |
345 |
$7K |
| 81003 |
|
3,221 |
2,615 |
$6K |
| 59430 |
|
426 |
317 |
$6K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
82 |
62 |
$5K |
| 90661 |
|
580 |
502 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
466 |
214 |
$5K |
| 90670 |
|
3,293 |
3,051 |
$5K |
| 83655 |
|
367 |
304 |
$5K |
| 92587 |
|
324 |
197 |
$5K |
| 99173 |
|
1,146 |
1,022 |
$4K |
| 90674 |
|
759 |
637 |
$4K |
| 3008F |
|
3,824 |
3,150 |
$3K |
| 82950 |
|
561 |
463 |
$3K |
| 90697 |
|
860 |
694 |
$3K |
| 90677 |
|
976 |
752 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
20 |
12 |
$2K |
| 99401 |
|
92 |
67 |
$2K |
| 90688 |
|
281 |
212 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
86 |
73 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
12 |
12 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
13 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
16 |
13 |
$1K |
| 90680 |
|
1,729 |
1,511 |
$1K |
| 99442 |
|
55 |
52 |
$1K |
| 90756 |
|
71 |
42 |
$1K |
| 99462 |
|
46 |
36 |
$1K |
| 85018 |
|
366 |
310 |
$948.49 |
| 96160 |
|
38 |
28 |
$856.75 |
| 90698 |
|
430 |
396 |
$853.50 |
| 92558 |
|
146 |
107 |
$731.68 |
| 99443 |
|
15 |
15 |
$599.91 |
| 0502F |
|
19,638 |
14,479 |
$520.00 |
| 83037 |
|
57 |
54 |
$505.23 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
48 |
46 |
$489.97 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
13 |
12 |
$399.76 |
| 90633 |
|
678 |
573 |
$203.01 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
36 |
27 |
$183.70 |
| 90734 |
|
34 |
28 |
$155.00 |
| 90716 |
|
198 |
173 |
$150.98 |
| 90744 |
|
79 |
67 |
$121.76 |
| 90723 |
|
656 |
624 |
$90.05 |
| 90648 |
|
1,341 |
1,268 |
$87.47 |
| 90707 |
|
153 |
125 |
$87.31 |
| 91301 |
|
797 |
632 |
$16.94 |
| 0501F |
|
137 |
117 |
$0.00 |
| 90657 |
|
67 |
46 |
$0.00 |
| 90651 |
|
113 |
92 |
$0.00 |
| 3044F |
|
48 |
40 |
$0.00 |
| 90656 |
|
16 |
15 |
$0.00 |
| 90696 |
|
32 |
27 |
$0.00 |
| 90700 |
|
165 |
147 |
$0.00 |
| 90710 |
|
63 |
56 |
$0.00 |
| 90681 |
|
150 |
140 |
$0.00 |
| 99080 |
|
295 |
267 |
$0.00 |
| 90658 |
|
41 |
36 |
$0.00 |